A Phase I Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of CKD-391(2) and Co-administration of CKD-331 and D337 in Healthy Adult Volunteers
Latest Information Update: 01 Apr 2024
At a glance
- Drugs CKD 331 (Primary) ; D 337 (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics
Most Recent Events
- 26 Mar 2024 Status changed from not yet recruiting to completed.
- 20 Oct 2023 New trial record